Market Analysis

Market Analysis Submit Abstract Register Now

There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion to 2024.

  • Regenerative medicine research in World
  • Human Tissue Market in Asia
  • Tissue analysis products Market in USA
  • Stem cell analysis products Market in UK

Market Analysis Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in